Literature DB >> 10092002

Susceptibility of TT virus to interferon therapy.

K Chayama, M Kobayashi, A Tsubota, M Kobayashi, Y Arase, Y Suzuki, S Saitoh, N Murashima, K Ikeda, K Okamoto, M Hashimoto, M Matsuda, H Koike, M Kobayashi, H Kumada.   

Abstract

TT virus (TTV) is a newly identified single-stranded DNA virus. We retrospectively analysed serum samples from sixteen patients, infected with both hepatitis C virus (HCV) and TTV, and who had been treated with interferon. An elevated serum alanine aminotransferase level after interferon was associated with persistence of HCV (abnormal in five of seven patients with persistence of HCV compared with normal in all nine patients who showed eradication of HCV) irrespective of persistence of TTV. Comparison of partial viral DNA nucleotide sequences and phylogenetic analysis showed that viral strains that had a high identity to the prototype virus were more resistant to interferon than those showing low nucleotide sequence identity. Although we observed no liver cell injury caused by persistent TTV infection, the mechanism(s) of TTV resistance to interferon should be further investigated for a better understanding of viral diseases and establishment of therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092002     DOI: 10.1099/0022-1317-80-3-631

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  4 in total

Review 1.  Transfusion transmitted virus: A review on its molecular characteristics and role in medicine.

Authors:  M Irshad; Y K Joshi; Y Sharma; I Dhar
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

Review 2.  Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans.

Authors:  M Bendinelli; M Pistello; F Maggi; C Fornai; G Freer; M L Vatteroni
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

3.  Coinfection of TT virus and response to interferon therapy in patients with chronic hepatitis B or C.

Authors:  Yung-Chih Lai; Ruey-Tyng Hu; Sien-Sing Yang; Chi-Hwa Wu
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

Review 4.  What do we need to know about non-A-to-E viral hepatitis?

Authors:  K V Menon; N N Zein
Journal:  Curr Gastroenterol Rep       Date:  2000-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.